ジヒドロタキステロール

From Azupedia
Revision as of 22:28, 12 April 2024 by Fire (talk | contribs) (Created page with "{{Drugbox | verifiedrevid = 460787840 | IUPAC_name = (1''S'',3''E'',4''S'')-3-[(2''E'')-2-[(1''R'',3a''S'',7a''R'')-1-[(''E'',2''R'',5''R'')-5,6-Dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1''H''-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol | image = Dihydrotachysterol.svg | alt = 構造式 | image2 = Dihydrotachysterol molecule spacefill.png | alt2 = ジヒドロタキステロール分子の空間充填モデル | width = 190 <!--Clinical data--> |...")

Dihydrotachysterol/ja
Jump to navigation Jump to search
Dihydrotachysterol/ja
構造式
ジヒドロタキステロール分子の空間充填モデル
Clinical data
AHFS/Drugs.comMicromedex Detailed Consumer Information
MedlinePlusa682335
ATC code
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
Chemical and physical data
FormulaC28H46O
Molar mass398.675 g·mol−1
3D model (JSmol)
  (verify)

Dihydrotachysterol (DHT) is a synthetic vitamin D analog activated in the liver that does not require renal hydroxylation like vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). DHT has a rapid onset of action (2 hours), a shorter half-life, and a greater effect on mineralization of bone salts than does vitamin D.